The Counterfeit Detection Device #3, or CD3, is a handheld device. It emits wavelengths of light that can be used on tablets and capsules, powders and packaging, according to the report. It is designed to perform real-time comparisons with authentic drugs. It is intended to detect tampered, re-labeled or re-glued products.
The CD3 is currently in use at FDA field laboratories, border crossings, import centers and international mail facilities.
Related Articles on FDA:
Recall Issued for Anesthesia Pump with ONDEMAND Bolus Button
Covidien Receives FDA Clearance of Small Jaw Instrument for ENT Surgical Procedures
Precision Spine Receives FDA Clearance for Anterior Cervical Plate System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.